Kiniksa Pharmaceuticals International, plc (KNSA)

NMS – Цена в реальном времени. Валюта: USD

78.11

+0.31 (0.40%)

При закрытии: Aug 12, 2026, 3:59 PM EDT

78.00

-0.15 (-0.19%)

После закрытия: Aug 12, 2026, 4:56 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

07.08.2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time.

03.08.2026

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

KNSA lifted 2026 ARCALYST sales guidance as Q2 revenue surged, while advancing KPL-387 into Phase 3 to support its next growth driver.

Видео

No Data

There is no data to display

Kiniksa Pharmaceuticals International, plc (KNSA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Видео

No Data

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Видео

No Data

Search stocks

Kiniksa Pharmaceuticals International, plc (KNSA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Видео

No Data

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Видео

No Data